Voloridge Investment Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-39,083
Closed -$934K 1872
2021
Q1
$934K Buy
+39,083
New +$726K 0.01% 1037
2020
Q3
Sell
-28,340
Closed -$417K 1578
2020
Q2
$417K Buy
+28,340
New +$288K ﹤0.01% 1067

Voloridge Investment Management's GNMK Position: Q2 2021 in Review

Voloridge Investment Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 39,083 shares — an estimated $934K sold.

Voloridge Investment Management first reported a position in GNMK in Q2 2020 and held it in 2 quarters. The position peaked at $934K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Voloridge Investment Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Voloridge Investment Management sold 39,083 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $934K.
  • Voloridge Investment Management first reported a position in GenMark Diagnostics, Inc in Q2 2020 and held it in 2 quarters.
  • Voloridge Investment Management's GenMark Diagnostics, Inc position peaked at $934K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Voloridge Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.